Skip To Main Content
Trine Rolighed Thomsen on Muck Rack

Trine Rolighed Thomsen

As seen in: Diabetes Research and Clinical Practice
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Trine Rolighed

Contact Trine Rolighed, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Glucagon-like Peptide-1 Treatment Reduces the Risk of Diabetes-Type 2 Related Amputations: A Cohort Study in Denmark

|
By Peter Rossing, Zeinab Schäfer, Andreas Mathisen, Trine Rolighed Thomsen
| Diabetes Research and Clinical Practice Verified
To assess the impact of Glucagon-like peptide-1 (GLP-1) agonists on the risk of lower extremity amputations in patients with type 2 diabetes mellitus (DM2). We conducted a cohort study on 309,116 patients with DM2 using Danish National Register and Diabetes Database. We tracked the GLP-1 agonists over time along with the medication dose. Time-varying models are used to assess the risk of amputation for patients with/without GLP-1 treatment.
Open in Who Shared Issue with article?
See all 1 articles